Getinge to acquire High Purity New England, Inc., a leading provider of single-use solutions for bioprocessing applications
Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications.“This acquisition is another step in Getinge Life Science strategic journey to further expand our presence in the biopharma segment”, says Eric Honroth, President Life Science at Getinge. “High Purity New England (HPNE) has in recent years successfully supplied the industry with dedicated single use assemblies. We are delighted to join forces with HPNE providing our customers